Nidana. The diagnostic-pathology stream, operated by Medilab.
Nidana is the hotel's diagnostic-pathology stream inside Sama Clinic — a fitted blood-draw room on the clinic floor, staffed and operated by Medilab (the Jersey-based, consultant-led medical laboratory at Strive in St Peter) under a service contract. Named after Sanskrit nidana — cause, diagnosis, the classical Ayurvedic term for the diagnostic process itself. The room-and-clinician side sits with Medilab; the clinical interpretation, guest consultations, protocol design, and onward referral all sit with the Long Hotel medical team on our own premises. Two well-scoped operations, working together, each doing what it does best. The hotel's own clinical framework — the five-clinician team, the Medical Director role, the referral pathways — is set out on the Sama Clinic page.
A longevity hotel without diagnostics is a spa with extra steps.
The category we are entering — the premium longevity programme — is defined, more than anything else, by what it measures. Lanserhof, Chenot, RAKxa, SHA Wellness, Clinique La Prairie, the Mayr Cure clinics: each charges what it charges because the guest leaves with a quantitative record of their physiology that they did not arrive with. Cholesterol panels, hormone profiles, inflammatory markers, vitamin and mineral status, thyroid function, kidney and liver markers, fasting glucose and HbA1c. The week itself is the intervention; the bloodwork is the evidence.
Without a diagnostic spine, the programme reduces to a beautifully run rest cure. That is a defensible product at £1,500 per week. It is not a defensible product at £4,655. The premium tier of this market does not pay for sleep and seaweed; it pays for measurement, interpretation, and the documented sense that something specific has changed.
The strategic question is therefore not whether The Long Hotel needs a diagnostic capability. It is how the work is split between the hotel and its lab partner. The hotel carries the clinical work: the guest consultations, the interpretation, the protocol, the follow-up, the onward referral to Jersey's imaging and specialist providers. The lab carries the pathology: the phlebotomist, the analyser, the consumables, the consultant biochemist and haematologist sign-off, the ISO accreditation, the indemnity on the result itself. The case below is for Medilab specifically as that lab partner — a Jersey-based counterparty that already does everything on the lab side, and does it to a standard the programme can credibly cite.
Medilab — Jersey-based, consultant-led, already operating.
Medilab is a private medical laboratory based at Strive Health Club in St Peter, roughly fifteen minutes' drive from Hotel de France. We met with Rebecca Marshall, Muhammad "Raz" Razaq, and Umer Rehman to discuss what a programme partnership would look like in practice. Three things, taken together, make them the right counterparty.
Consultant-led lab sign-off
Results are signed off inside the laboratory by a Consultant Haematologist (Dr Keenan, twenty-plus years across paediatric and adult haematology, including malignant haematology, haemoglobinopathies and transfusion medicine) and a Consultant Clinical Biochemist (Dr Powell). This matters because it is what makes the lab result itself defensible — the number on the printout carries a consultant signature at the laboratory that issued it, which is the standard the hotel needs to cite when a guest asks whether the finding is real. Interpretation for the guest — the so what now conversation — sits with the Long Hotel medical team, whose Medical Director takes the flagged result and turns it into a protocol the guest can act on. The two responsibilities live in the right places: the lab stands behind the result, the hotel stands behind the intervention.
Mobile collection, not hotel-built phlebotomy
Medilab already operates a dedicated medical sample collection service on a scheduled or ad hoc basis. In practical terms, this means a Medilab phlebotomist comes to the hotel, draws blood in a designated room on the spa wing, labels and packages the samples to their internal protocol, and returns to the laboratory in St Peter the same morning. The hotel does not need to register as a healthcare premise, hold sharps waste contracts, or carry phlebotomy indemnity. The clinical responsibility sits with Medilab, where it belongs.
Two-working-day turnaround on-island
Most tests on the Medilab menu are run in their own laboratory with a two-working-day turnaround. For a programme structured around a Monday arrival and a Saturday departure, this is the difference between a guest leaving with their results in hand and a guest leaving with a promise to email them. The first is a £4,655 product; the second is not. Tests that require referral to a UK specialist laboratory go via Medilab's existing postal pathology service (Royal Mail Tracked 24 / DHL Tracked) — meaning we inherit their logistics rather than building our own.
Quality infrastructure already in place
Medilab is working toward ISO 15189 accreditation under UKAS — the international standard for medical laboratories. Internal and external quality control is already in operation. ISO 27001 information security controls govern how patient data is handled under GDPR. None of this is glamorous, but all of it is what the difference looks like between a laboratory we can credibly cite in our marketing and one we cannot. A guest paying £4,655 a week is paying, in part, for the assurance that the result is the right result.
What we can measure, organised by what it means.
Medilab's full test menu is extensive. What follows is not the alphabetical list — that is on their website and is not how a programme guest experiences it. What follows is the menu reorganised by clinical theme: the system or process each test illuminates. This is the structure that translates into a programme report a guest can actually read.
Cardiovascular and metabolic
The largest single bucket, and the bucket the programme will lead on. HDL Cholesterol, LDL Cholesterol, Triglycerides, Apolipoprotein A, Apolipoprotein B, Apolipoprotein E, Lipoprotein (a), Homocysteine, Glucose, HbA1c, Insulin, B-type natriuretic peptide (BNP), High-sensitivity cardiac troponin (hs-cTnT), High-sensitivity C-reactive protein (hs-CRP), Heart Type Fatty Acid Binding Protein (H-FABP), Alpha HBDH. What it lets us say: a quantitative cardiovascular risk picture, including the modern markers (ApoB, Lp(a), hs-CRP) that have moved beyond the simple total-cholesterol view and that informed guests increasingly expect to see.
Hormonal and reproductive
Testosterone (total and free), Estradiol, Progesterone, Prolactin, Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), Anti-Mullerian Hormone (AMH), Human Chorionic Gonadotropin (HCG), Cortisol, Insulin. What it lets us say: a sex-specific hormonal baseline that supports the longevity guest's most asked question — am I ageing on the inside the way I'm ageing on the outside — and that supports cycle-aware programming for women and andropause-aware programming for men.
Thyroid function
Thyroid Stimulating Hormone (TSH), Free T3, Free T4, Anti-Thyroid peroxidase (TPO), Anti Thyroglobulin Abs. What it lets us say: a complete thyroid panel, not just the screening TSH. Subclinical thyroid dysfunction is one of the most common findings in midlife adults and one of the most underdiagnosed sources of fatigue, weight change, and mood symptoms — exactly the symptoms a longevity programme is being asked to address.
Inflammation and immunity
C-reactive protein (CRP), High-sensitivity CRP (hs-CRP), Erythrocyte Sedimentation Rate (ESR), Plasma Viscosity, Antinuclear Antibody Screen (ANA), Anti-double-stranded DNA (ds-DNA), Anti-cyclic citrullinated peptide (anti-CCP), Antistreptolysin O (ASO), Extractable Nuclear Antigen (ENA) Screen, Rheumatoid Factor, Immunoglobulins A, E, G, M. What it lets us say: a systemic inflammation profile that lets the programme report on chronic inflammatory load — the single mechanism most consistently implicated in cardiovascular, metabolic, and neurodegenerative disease — and that flags autoimmune patterns warranting onward referral.
Liver and kidney function
Alanine Transaminase (ALT), Aspartate Aminotransferase (AST), Alkaline Phosphatase, Gamma-GT (GGT), Bilirubin, Albumin, Total Protein, Total Bile Acids, Urea, Creatinine, eGFR, Microalbumin (urine), Urate. What it lets us say: the two most informative organ-function panels we can run, and the two most likely to surface clinically actionable findings in midlife professionals — fatty liver, early kidney decline, gout risk.
Nutrient status and anaemia work-up
Ferritin, Iron, Iron Binding Saturation, Unsaturated Iron-Binding Capacity (UIBC), Transferrin, Vitamin B12 (total and active), Folate, Vitamin D, Magnesium, Calcium, Phosphate, Sodium, Potassium, Full Blood Count. What it lets us say: a nutrient-status read that the programme can act on within the same week — most of these are correctable, several of them dramatically so, and a guest who arrives fatigued and leaves with a vitamin-D-replete plan and a B12 protocol has experienced something the home GP has typically not delivered.
Bone, calcium, and parathyroid
Calcium, Phosphate, Parathyroid Hormone (PTH), Vitamin D, Alkaline Phosphatase, Magnesium. What it lets us say: a bone-metabolism baseline. Particularly relevant for the female longevity guest in the perimenopausal-to-postmenopausal window, where bone density is a question the programme should be able to speak to.
Tumour markers (screening, with appropriate framing)
Alpha-fetoprotein (AFP), Carcinoembryonic Antigen (CEA), CA125, CA15-3, CA19-9, Beta-2-Microglobulin, Neuron Specific Enolase (NSE). What it lets us say: available on request, with explicit clinical framing. These are not screening tests in asymptomatic populations and we should not market them as such. They have a role in monitoring known disease and in selected high-risk individuals after consultation. The programme should make them available — guests will ask — with the framing that interpretation requires Medilab's consultant input, not a checkbox on a form.
Travel and infectious disease
COVID-19 PCR, Malaria rapid diagnostic test, Infectious Mononucleosis screen, G6PD rapid diagnostic, Sickle cell rapid diagnostic. What it lets us say: not a programme centrepiece, but quietly useful. International guests sometimes arrive unwell; a same-day PCR or malaria RDT capacity is a service the hotel can offer through Medilab without making it a marketing point, and one international guests genuinely value when they need it.
The point of grouping the menu this way, rather than alphabetically, is that the programme report a guest takes home is not here are 73 numbers. It is here is what your cardiovascular system, your hormones, your thyroid, your inflammation, your organs and your nutrients are telling us, and here is what we recommend you do about each one over the next three, six, and twelve months. The lab supplies the numbers. The programme — and the consultant overlay Medilab provides — supplies the interpretation.
Four panels, one per programme tier.
The four programmes sit at meaningfully different price points and serve meaningfully different guests. The bloodwork that anchors them follows the same logic. A focused screening panel for the Long Weekend, a comprehensive baseline for the Long Pause, a flagship panel with mid-stay and departure rechecks for the Long Reset, and a deep panel with multiple time points and a posted three-month follow-up for the Long View. Each tier is bundled into the programme fee — not presented as an à la carte upgrade — and each is delivered with a Medilab clinician consultation so the guest leaves with their results explained, contextualised, and translated into a written protocol.
Indicative per-guest pricing is set out in each panel below. The figures reflect Medilab's current cost structure at present low volumes; a scheduled review at month six and again at month twelve is built into the proposed partnership terms, with each tier expected to fall by approximately 10% at fifty panels per month and 15% at one hundred. The figures below should be read as ceilings rather than floors as the programme scales.
Tier 1 · The Essential Panel — A Long Weekend
2–3 nights · single arrival draw · ~£90–£120 per guest, bundled in the programme fee
- Cardiometabolic — total cholesterol, HDL, LDL, triglycerides, HbA1c
- Liver function — ALT, AST, GGT, bilirubin, albumin
- Kidney function — urea, creatinine, eGFR
- Thyroid — TSH
- Inflammation — hs-CRP
- Nutrient status — vitamin D, ferritin, calcium, magnesium
- Haematology — full blood count
- Clinician consultation — fifteen-to-twenty-minute results consultation with the Long Hotel medical team, walking the guest through the panel
Why this composition. The smallest panel that still tells a guest something they did not already know. The five systems most likely to surface a clinically actionable finding in a forty-five-to-sixty-five-year-old wellness guest — metabolic, lipid, thyroid, inflammatory, nutrient — are all covered. Anything narrower starts to read as a wellness check rather than a longevity panel.
Tier 2 · The Longevity Baseline Panel — The Long Pause
5 nights · single arrival draw · ~£150–£220 per guest, bundled in the programme fee
- Cardiometabolic — total cholesterol, HDL, LDL, triglycerides, HbA1c
- Advanced lipids — ApoA, ApoB, Lp(a)¹
- Metabolic — fasting insulin (with HOMA-IR calculation)
- Liver function — ALT, AST, GGT, bilirubin, albumin
- Kidney function — urea, creatinine, eGFR
- Thyroid — TSH, free T4
- Inflammation — hs-CRP
- Nutrient status — vitamin D, ferritin, calcium, magnesium, B12 (active), folate, iron studies (iron, transferrin, TIBC, saturation), phosphate
- Sex hormones (women) — estradiol, FSH, LH, progesterone, plus AMH if pre-menopausal
- Sex hormones (men) — total testosterone, free testosterone
- Haematology — full blood count
- Clinician consultation — thirty-minute consultation with the Long Hotel medical team covering results, written protocol, and onward recommendations
Why this composition. Meaningfully deeper than Tier 1, moving the guest from screen to record. The advanced lipid panel, the HOMA-IR insulin reading, and the sex-hormone work are all things an informed guest now expects to see and that an NHS GP typically does not run. This is the panel that distinguishes the Long Hotel from a spa-hotel weekend.
¹ Lp(a) is a one-off lifetime test, repeated only every five years.
Tier 3 · The Comprehensive Longevity Panel — The Long Reset
5–7 nights · arrival, mid-week recheck, departure recheck · ~£300–£375 per guest, all draws and consultations bundled
Arrival draw — the full Medilab MediMan / MediWoman comprehensive panel
- Cardiometabolic — total cholesterol, HDL, LDL, triglycerides, HbA1c, fasting glucose, total cholesterol/HDL ratio (calculated), NT-proBNP where indicated
- Advanced lipids — ApoA, ApoB, Lp(a)
- Metabolic — fasting insulin with HOMA-IR
- Liver and bone — ALT, AST, GGT, bilirubin, albumin, alkaline phosphatase
- Kidney and electrolytes — urea, creatinine, eGFR, chloride, potassium, sodium, uric acid
- Pancreatic — pancreatic amylase
- Muscle and joint — creatine kinase, rheumatoid factor
- Bone metabolism — parathyroid hormone where indicated
- Thyroid — TSH, free T4
- Inflammation — hs-CRP
- Nutrient status — vitamin D, ferritin, calcium, magnesium, B12 (active), folate, iron studies, phosphate
- Sex hormones (women) — estradiol, FSH, LH, progesterone, AMH if pre-menopausal, plus cortisol and prolactin
- Sex hormones (men) — total and free testosterone, plus total PSA
- Haematology — full blood count
Mid-week recheck (where indicated)
- Targeted recheck on whatever the programme is actively addressing — most commonly hs-CRP, fasting glucose, fasting insulin
Departure recheck
- Lipids, hs-CRP — the most movement-sensitive markers, repeated to evidence change
Clinician consultations
- Twenty-minute pre-arrival call setting context, plus a forty-five-minute post-stay consultation reviewing arrival, mid-stay, and departure data side by side
Why this composition. The flagship has to bear comparison with Lanserhof and SHA. That comparison is won not by matching marker count but by matching the clinical loop: arrival, in-stay action, departure measurement, take-home report. The mid-week recheck is what makes the loop real — it lets the medical team evidence change rather than promise it. The arrival panel covers approximately one hundred individual data points across every major system. The closing consultation walks the guest through arrival vs departure side by side. This is the moment the programme either justifies its price or fails to.
Tier 4 · The Deep Longevity Panel — The Long View
10–14 nights · arrival, mid-stay, departure, posted three-month follow-up · ~£500–£600 per guest, all four time points and consultations bundled
Arrival draw — the full Tier 3 comprehensive panel, plus:
- Cancer markers (men) — AFP, CEA, CA15-3, CA19-9, beta-HCG, LDH (total PSA already in the comprehensive panel)
- Cancer markers (women) — AFP, CEA, CA125, CA15-3, CA19-9, LDH
- Body composition — Styku 3D infrared scan
Mid-stay recheck
- Targeted recheck on flagged markers
Departure draw and scan
- Movement-sensitive markers repeated, plus second Styku 3D scan for arrival vs departure body composition comparison
Posted three-month follow-up — sent to the guest's home country
- Lipids, ApoB, HbA1c, hs-CRP, ferritin, vitamin D, plus key flagged markers from arrival
Clinician consultations across the four time points
- Thirty-minute pre-arrival call · forty-five-minute arrival results consultation · thirty-minute departure consultation · thirty-minute video review three months after the guest's return
Why this composition. The Long View goes head-to-head with Lanserhof's two-week longevity programme and SHA's Healthy Ageing pathway. Both run extensive bloodwork at multiple time points; the Long View matches that and adds two further differentiators — a cancer marker panel that gives the guest a baseline read across the major sites, and the Styku 3D scan that produces the most photographable before-and-after of the entire programme. The three-month posted follow-up, paired with a clinician review of the result, is the most important clinical touch in the entire programme architecture: it is the difference between a guest who once visited and a guest who is on a programme. Medilab's existing UK postal pathology service makes the follow-up operationally straightforward.
The four tiers ladder cleanly. A guest who completes a Long Weekend has a baseline; if they return for a Long Pause they get the deeper read against that baseline; if they return for a Long Reset they enter the longitudinal three-draw structure; if they return for a Long View they enter the four-time-point relationship that converts the hotel from a destination into a programme. The same logic supports the membership tier the forecast assumes by Year 2 — annual longevity audits with bloodwork bookending each stay and a postal follow-up between them, anchored by Medilab as the underlying clinical infrastructure.
All-in cost per programme, with bloodwork bundled.
The bloodwork is included in the programme fee at every tier rather than offered as an à la carte upgrade. The table below sets out what each programme costs the hotel in clinical input — programme fee, bloodwork tier, what the panel covers, the bloodwork cost range, and the total cost the hotel carries per guest before any other variable cost.
| Programme | Programme fee | Bloodwork tier | Bloodwork cost | All-in |
| A Long Weekend 2–3 nights · screening panel, single arrival draw, fifteen-to-twenty-minute consultation |
£695 | Tier 1 — Essential | ~£90 – £120 | ~£785 – £815 |
| The Long Pause 5 nights · longevity baseline, single arrival draw, thirty-minute consultation |
£1,495 | Tier 2 — Baseline | ~£150 – £220 | ~£1,645 – £1,715 |
| The Long Reset 5–7 nights · comprehensive panel, three draws (arrival, mid-week, departure), pre-arrival call plus forty-five-minute post-stay consultation |
£2,950 | Tier 3 — Comprehensive | ~£300 – £375 | ~£3,250 – £3,325 |
| The Long View 10–14 nights · deep panel, four time points (arrival, mid, departure, posted three-month follow-up), Styku scans, four scheduled consultations |
£7,500 | Tier 4 — Deep | ~£500 – £600 | ~£8,000 – £8,100 |
What this tells us about the cost structure. Bloodwork represents a meaningfully higher share of the hotel's cost on the entry tiers than on the flagship — roughly 13-17% of the Long Weekend fee, 10-15% of the Long Pause, 10-13% of the Long Reset, and 7-8% of the Long View. The implication is that the volume-discount work matters most on Tiers 1 and 2 specifically, where every percentage point of bloodwork cost compresses the programme margin more sharply than it does on the flagship. The Long View is robust to indicative pricing being on the higher end of the range; the Long Weekend is not. Securing favourable Tier 1 and Tier 2 pricing through the scheduled volume reviews is therefore the most material commercial outcome of the partnership negotiation.
All-in figures are programme fee plus indicative bloodwork cost only. Other variable costs (room, food, treatments, clinical-lead time beyond Medilab consultations) are not included.
Five further measurements, available as upgrades or programme inclusions.
Five further additions sit naturally alongside the tiered panels. Each could be a programme inclusion, a guest-paid upgrade, or a marketing differentiator depending on positioning.
Styku 3D body composition scan
A non-ionising, infrared 3D scan that produces a detailed body map in under sixty seconds. Complements rather than replaces DEXA — DEXA is the clinical body-composition standard; Styku is the visual one. The image is highly photographable and creates an extremely strong before-and-after experience for the guest. Included as standard in Tier 4. Available as an upgrade at any other tier at indicative cost £75–£100 per scan via Medilab's existing Styku partnership.
Continuous glucose monitor for the duration of stay
A two-week CGM patch (Abbott Libre or Dexcom) gives the guest a real-time view of their glycaemic response to the food being served at Ahara. Indicative cost £150–£200 per stay. Best fit for the Long Reset and Long View, where the data window is long enough to be meaningful. A genuinely strong content moment — the guest leaves having literally seen what their breakfast does to their blood sugar.
One-off lifetime genetic panel
A single saliva sample, sent to a UK reference laboratory, returning a panel covering APOE (Alzheimer's risk), MTHFR (methylation), HFE (iron handling), CYP1A2 (caffeine metabolism), VDR (vitamin D), ACTN3 (exercise response), COMT (oestrogen metabolism and stress), and a small number of other lifestyle-relevant genes. Done once in a guest's lifetime, informs decisions across decades. Provider scoping in progress; final pricing to be confirmed. Best fit for the Long View at launch; potentially a Long Reset add-on at the guest's request.
Sleep apnea screening — AcuPebble by Acurable
Sleep apnea is a clinically significant finding for a longevity programme specifically because of its downstream hormonal effects: sustained low blood-oxygen levels during sleep suppress testosterone production and reduce the likelihood of reaching REM sleep — two outcomes directly at odds with what every programme tier is trying to achieve. It is also, historically, underdiagnosed because the standard investigation (a polysomnography referral) is inconvenient enough that most people who suspect a problem never pursue it.
The workflow is data-driven rather than universal. Orion's overnight respiratory monitoring flags guests whose breathing patterns are consistent with apnea risk. The initial clinical consultation also asks directly about snoring — a meaningful independent predictor — so that guests who present as low-risk on Orion but snore regularly are also captured. Guests who are flagged on either signal are offered the AcuPebble for a single night's sleep. The AcuPebble is a small acoustic sensor worn on the throat that continuously captures swallowing and breathing sounds overnight; Acurable processes the data and returns a clinical-grade apnea report at a cost of £60 per report, which The Long Hotel absorbs into the programme fee. The result either closes the question or gives the guest a documented finding they can take to their physician at home.
No extra equipment beyond the sensor is needed, and the test sits entirely within a single night of the guest's stay. The case for offering it is strong: the Orion data is already being collected, the incremental cost per flagged guest is modest, and a programme that surfaces an undiagnosed apnea diagnosis for a guest is delivering genuinely high-value clinical insight — the kind that a five-star room and a good dinner cannot.
DUTCH hormone panel — dried urine metabolite testing
The DUTCH test (Dried Urine Test for Comprehensive Hormones, Precision Analytical) sits alongside — not instead of — the serum hormone panels already in Tiers 2, 3 and 4. The two tests answer different questions: serum tells you where the hormones are right now; DUTCH tells you how the body is metabolising and clearing them. For the perimenopausal, fertility, and skin-longevity cohorts, the metabolism read is often the more actionable of the two.
The panel captures the 24-hour cortisol pattern from four timed dried-urine spots, cortisol metabolites (11β-HSD activity), the 2-OH / 4-OH / 16-OH oestrogen metabolite ratios (relevant to oestrogen-related conditions and to breast cancer risk assessment), COMT methylation activity, progesterone metabolites, the androgen breakdown pathway (testosterone → DHT and 5α vs 5β reductase), 6-sulfatoxymelatonin as a sleep-signal integrator, and a small panel of organic acid markers relevant to B-vitamin status and neurotransmitter turnover.
Indicative retail cost: £250–£350 per test, run once at intake and again after six to twelve months of protocol. Best fit as an optional add-on across every longevity tier from Tier 2 up, and a standard inclusion where clinically indicated on the Fertility programme and on Kanti's perimenopausal-skin cohort — the two guest groups most obviously served by the metabolism picture. Interpreted alongside the serum panel by the clinical lead and, where relevant, the aesthetic doctor and health coach jointly.
What each tier costs at the programme level.
The commercial value of the Medilab partnership is not the unit cost of the bloods. It is the strength of the proposition the bloods unlock, the longitudinal relationship the postal follow-up creates, and the externalisation of the pathology regulatory and accreditation burden to a counterparty already carrying it — leaving the hotel to focus its own clinical spend where it belongs, on the guest-facing medical team. The tiered pricing also lets the programme economics flex with mix — a Year 1 leaning toward the Weekend and Pause carries a lower bloodwork cost-per-guest than a Year 3 leaning toward the Reset and View, exactly when the higher-margin programmes can absorb the higher panel cost.
| Per-guest panel cost (per Medilab's April 2026 indicative pricing) | |
| Tier 1 — Long Weekend (single draw, consultation) | ~£90 – £120 / guest |
| Tier 2 — Long Pause (single draw, consultation) | ~£150 – £220 / guest |
| Tier 3 — Long Reset (three draws, two consultations) | ~£300 – £375 / guest |
| Tier 4 — Long View (four time points, three consultations, Styku scans) | ~£500 – £600 / guest |
| Year 1 indicative total at 200 programme guests, weighted across tiers | ~£40k – £75k |
Volume mechanism. Medilab proposes a scheduled pricing review at month six and again at month twelve, with each tier expected to fall by approximately 10% at fifty panels per month and 15% at one hundred. A bilateral partnership rate would be agreed once committed annual volumes are visible. Medilab has indicated willingness to commit to a transparent pricing methodology — list price, volume discount, partnership rate — that the hotel can stand behind in front of guests.
Per-tier figures are Medilab's indicative pricing as of April 2026 and will be confirmed in the formal commercial proposal.
An on-site laboratory at sufficient volume — under discussion, not a Phase 02 commitment.
Medilab currently operates from its Strive facility in St Peter, with mobile collection at the hotel and a two-working-day turnaround on the major panels. That is the Phase 02 baseline and what the rest of this page describes. Medilab and the hotel have separately discussed a longer-term option in which Medilab would relocate part of its operation — the analyser, a draw room, and a designated phlebotomist — onto the hotel premises once programme volumes justify it. The conversation is live, mutually interesting, and worth flagging to the board now while the data architecture is being designed; it is not part of what is being commissioned in Phase 02.
Trigger condition — volume, not calendar
The right time for this conversation is once Phase 02 is operating and the actual programme volumes are visible. Medilab's view, which we share, is that an on-site lab makes sense at roughly 200–300 panels per month — meaningfully above the 100-panel threshold that triggers the second indicative pricing review. At that volume the analyser is being used heavily enough to justify a dedicated install rather than a shared one at Strive, and the per-panel logistics economics tip in favour of co-location. Below that volume, the existing Strive arrangement remains operationally and commercially correct.
What an on-site lab would actually involve
A modest fit-out within the hotel's existing clinical space — a draw room with phlebotomy chair and supplies, a designated analyser room with appropriate ventilation and bench, a small sample storage and processing area, and IT infrastructure connecting back to Medilab's lab information system. Total footprint roughly forty to sixty square metres. Medilab would carry the analyser, lab consumables, accreditation, and clinical staff cost; the hotel would contribute the space, the fit-out to clinical specification, and a share of the running cost the lab does not generate from external work. The exact commercial split is a future negotiation rather than a current commitment.
What it would change about the proposition
Three things shift. First, turnaround moves from two working days to same-day on the major panels, which means a guest's arrival bloodwork can shape the same day's clinical conversation rather than the second-half-of-week one. That tightens the programme materially on the Long Reset and Long View, where the medical team's ability to act on results within the stay is the differentiator. Second, the marketing claim becomes meaningfully stronger — "lab on site" is the line Lanserhof and Surrenne both make, and it differentiates the programme from any spa-hotel partnership-based competitor. Third, Medilab's adjacency creates a potential extension into private-patient work for non-programme guests and Jersey residents — an additional revenue line for both businesses that the current arrangement cannot support.
Why this is not a Phase 02 line item
Three reasons. The capex case requires demonstrated volumes to justify; building speculatively before volumes are clear is the wrong way round. The space allocation is meaningful — forty to sixty square metres of clinical-spec fit-out is a real commitment that should follow rather than precede operating evidence. And the commercial terms are best agreed bilaterally once both businesses have lived with the partnership for twelve months and know what each is bringing. Phase 02 launches with the existing Strive arrangement; the on-site question opens at the second pricing review or when volumes cross the threshold, whichever comes first.
The point of flagging this now, in the Phase 02 board pack, is structural rather than commercial. If the data architecture, the clinical-space planning, and the IT integration with Medilab are designed in Phase 02 to anticipate a possible future on-site arrangement — rather than designed against it — the option remains open at low cost. If they are designed without that consideration, the option closes off and would have to be re-engineered later. This is a Phase 02 design discipline, not a Phase 02 spend. Medilab and the hotel are in agreement on this framing.
The marketing implications, stated plainly.
The Medilab partnership is not just a back-office decision. It is a marketing capability. Five things the programme can credibly say from day one with this partnership in place, that it cannot credibly say without it.
The arrival promise
"Your week begins with comprehensive bloodwork, drawn on arrival in your suite, processed in our partner laboratory in Jersey with consultant-level lab sign-off, and reviewed by your Long Hotel medical team before your first clinical consultation." Every clause in that sentence is true. Almost no longevity hotel in the UK can say it.
The departure proof
"You leave with a documented, side-by-side record of how your physiology has shifted across the week." The departure marker draw, against the arrival baseline, is what makes this true. It is also the single most defensible answer to the inevitable guest question — what did this week actually do for me.
The relationship beyond the week
"Three months after you leave, we send a sample collection kit to your home and run the same panel again." The longitudinal piece converts a one-off transaction into a relationship and gives the programme its repeat-purchase mechanic. Medilab's existing postal-pathology infrastructure makes it operationally trivial.
The credibility floor
"Our laboratory partner is working toward UKAS accreditation against ISO 15189 and operates ISO 27001 information security controls under GDPR." The dull sentence, but the necessary one. It is what separates this programme from the wellness retreat down the road that runs finger-prick tests of unstated provenance.
The on-island advantage
"The bloods are run on-island. Most results are with your physician inside two working days." The two-day turnaround is what makes the recheck and departure-marker rhythm possible. Mainland-only laboratories add three to five days of postal lag and rule the model out.
What is needed to move from conversation to contract.
The discussion with Rebecca, Raz, and Umer was exploratory. Three things are needed to convert it into a working partnership.
Commercial proposal
From Medilab to The Long Hotel
Per-panel pricing for the four-touchpoint structure described above, an annual retainer or minimum-volume commitment, exclusivity terms, and the SLA on turnaround and physician sign-off. Targeted within four weeks of board approval of this direction.
Operational walkthrough
Joint, on-site at the hotel and at the Medilab laboratory at Strive
Walk the physical journey of a sample from the spa wing draw room to the laboratory, identify the room that becomes the dedicated draw space, agree the cold-chain and labelling protocol on the hotel side, and brief the spa wing staff on what they do and do not do (they greet the guest; they do not handle the sample).
Laboratory service-level agreement
Between the Long Hotel medical team and Medilab's consultant biochemist and haematologist
A short written agreement covering the handoff points: when a critically abnormal result triggers same-day Medilab consultant escalation to the hotel's Medical Director, how flagged non-critical results are surfaced in the hotel's next clinical review, and the indemnity boundary between the lab (result correctness) and the hotel (interpretation and intervention). Boring document, essential document. The hotel's own clinical governance framework — the five-clinician team, the referral pathways, the scope-of-practice boundaries — is set out on the Sama Clinic page and is not part of this agreement.
None of the three is hard. All three need to be done before Phase 02 launch. Without them, the programme is selling something it cannot deliver. With them, the programme has a clinical credibility most of its competitors will not be able to match.